Literature DB >> 9115158

Diurnal variation of bone mineral turnover in elderly men and women.

S L Greenspan1, R Dresner-Pollak, R A Parker, D London, L Ferguson.   

Abstract

The diurnal variation of markers of bone mineral metabolism have been documented in pre- and early postmenopausal women. Such rhythms have clinical implications for timing of sample collection and assessment of therapeutic intervention. To examine the diurnal variation of bone turnover in the elderly, we examined markers of bone formation [serum osteocalcin (OC) and bone-specific alkaline phosphatase (B-ALP)]; a marker of bone resorption (urinary N-telopeptide cross-linked collagen type 1 [NTX]); and serum calcium and parathyroid hormone (PTH) over 24 hours. Subjects were healthy community-dwelling elderly who were on no medications known to significantly alter bone mineral metabolism. Subjects included 14 women [74 +/- 6 years (mean +/- SD)] and 14 men (80 +/- 5 years). Over the 24-hour sampling period, mean serum OC, B-ALP, and calcium values were similar in elderly men and women. However, mean serum PTH was significantly higher in elderly men compared with women (P < 0.05). The magnitude of the diurnal variation of urinary NTX was significantly higher in women compared with men (P < 0.05). There was a significant diurnal variation for serum OC, B-ALP, calcium, PTH, and urinary NTX in both elderly men and women. The magnitude of the diurnal variation was approximately 10-20% of mean value for OC and B-ALP, 30% for PTH, and up to 40% for urinary NTX. We conclude that there is significant diurnal variation in the markers of bone mineral metabolism for elderly men and women. The peak value, which on average would be 20% higher than the mean value for urinary NTX, highlights the importance of the timing of sample collection for appropriate interpretation of therapeutic response. In addition, gender-related differences, including relatively higher levels of serum PTH and lower levels of urinary NTX in elderly men, may help explain differences in rates of bone loss in this age group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115158     DOI: 10.1007/s002239900256

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  26 in total

Review 1.  Diagnosis of postmenopausal osteoporosis: reviews in endocrine and metabolic disorders.

Authors:  A T Shields; C H Chesnut
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.

Authors:  John T Schousboe; Douglas C Bauer
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 3.  Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors:  Serge Cremers; Patrick Garnero
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  The associations of bedtime, nocturnal, and daytime sleep duration with bone mineral density in pre- and post-menopausal women.

Authors:  Kun Wang; Yang Wu; Yu Yang; Jie Chen; Danyu Zhang; Yongxin Hu; Zhoujun Liu; Juan Xu; Qiaoxuan Shen; Niya Zhang; Xiaodong Mao; Chao Liu
Journal:  Endocrine       Date:  2014-12-02       Impact factor: 3.633

5.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

6.  Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.

Authors:  Masayuki Iki; Takashi Akiba; Toshio Matsumoto; Harumi Nishino; Sadanobu Kagamimori; Yoshiko Kagawa; Hideo Yoneshima
Journal:  Osteoporos Int       Date:  2004-07-31       Impact factor: 4.507

7.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

Review 8.  Melatonin and the skeleton.

Authors:  A K Amstrup; T Sikjaer; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

9.  Nightshift work and fracture risk: the Nurses' Health Study.

Authors:  D Feskanich; S E Hankinson; E S Schernhammer
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

Review 10.  From space to Earth: advances in human physiology from 20 years of bed rest studies (1986-2006).

Authors:  A Pavy-Le Traon; M Heer; M V Narici; J Rittweger; J Vernikos
Journal:  Eur J Appl Physiol       Date:  2007-07-28       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.